Power Law company profile

Euglena

Biotech & Life Sciences · Tokyo, Japan · Founded 2005 · IPO 2012 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$489M

Market cap · Apr/2026

Revenue

$388M

Latest reported FY

Investors

4 investors on Euglena's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage

Series B+ 2 investors entered at this stage

Global footprint

Web traffic by country

160K monthly visits
across markets

🇯🇵 Japan98.6%

🇺🇸 United States1.4%

🇬🇧 United Kingdom0.8%

🏳️ Korea0.7%

🏳️ Republic of0.6%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo